NasdaqCM - Delayed Quote USD
Zura Bio Limited (ZURA)
1.0200
-0.0200
(-1.92%)
At close: May 23 at 4:00:01 PM EDT
1.0499
+0.03
+(2.93%)
After hours: May 23 at 4:18:58 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.15 | -0.13 | -0.16 | -0.16 |
| EPS Actual | -0.17 | -0.26 | -0.08 | -0.19 |
| Difference | -0.02 | -0.13 | 0.08 | -0.03 |
| Surprise % | -13.33% | -100.00% | 50.00% | -19.82% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ZURA | -- | -- | -- | -- |
| S&P 500 | 12.56% | 2.53% | 7.37% | 14.09% |
Upgrades & Downgrades
| Maintains | Oppenheimer: Outperform to Outperform | 5/9/2025 |
| Maintains | HC Wainwright & Co.: Neutral to Neutral | 4/3/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 3/26/2025 |
| Reiterates | Guggenheim: Buy to Buy | 3/26/2025 |
| Maintains | Chardan Capital: Buy to Buy | 3/26/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 12/24/2024 |
Related Tickers
ACRV Acrivon Therapeutics, Inc.
1.1700
+1.74%
ERAS Erasca, Inc.
1.2200
+0.83%
KPRX Kiora Pharmaceuticals, Inc.
3.0600
-1.45%
LXEO Lexeo Therapeutics, Inc.
2.8200
-8.44%
BCAX Bicara Therapeutics Inc.
9.27
-40.80%
ORKA Oruka Therapeutics, Inc.
10.95
-2.14%
IPHA Innate Pharma S.A.
2.1600
-0.92%
KZR Kezar Life Sciences, Inc.
3.9300
-1.75%
PLRX Pliant Therapeutics, Inc.
1.2900
-3.73%
AVTX Avalo Therapeutics, Inc.
3.7500
-4.09%